TSXgroup

March 7, 2008

TRANSFORMATIVE VENTURES LTD. ("TNV.P")
BULLETIN TYPE: New Listing-CPC-Shares
BULLETIN DATE: March 7, 2008
TSX Venture Tier 2 Company

This Capital Pool Company's ('CPC') Prospectus dated February 25, 2008 has been filed with and accepted by TSX Venture Exchange and the British Columbia, Alberta and Ontario Securities Commissions effective February 26, 2008, pursuant to the provisions of the British Columbia, Alberta and Ontario Securities Acts. The Common Shares of the Company will be listed on TSX Venture Exchange on the effective date stated below.

The Company has completed its initial distribution of securities to the public. The gross proceeds received by the Company for the Offering were $700,000 (7,000,000 common shares at $0.10 per share).

Commence Date: At the opening March 10, 2008, the Common shares will commence trading on TSX Venture Exchange.

Corporate Jurisdiction: British Columbia

Capitalization: unlimited common shares with no par value of which 12,500,000 common shares are issued and outstanding.
Escrowed Shares: 5,200,000 common shares

Transfer Agent: Pacific Corporate Trust Company
Trading Symbol: TNV.P
CUSIP Number: 89366Y 10 6
Sponsoring Member: Canaccord Capital Corporation

Agent's Options: 700,000 non-transferable stock options. One option to purchase one share at $0.10 per share up to 24 months.

For further information, please refer to the Company's Prospectus dated February 25, 2008.

Company Contact: James Beesley
Company Address: Suite 109 - 175 1st Street, North Vancouver, BC V7M 3N9
Company Phone Number: (604) 813-0133
Company Fax Number: (604) 929-0135
Company Email Address: jbeesley@protoxtherapeutics.com